Corona Remedies IPO, Dec. 14 -- Corona Remedies' initial public offering (IPO) is all set to be listed on the Indian stock market on Monday, 15 December 2025, as the GMP levels signal a strong debut ahead.

The company received a strong response from the stock market investors during its three-day bidding round as the Corona Remedies IPO was booked 137.04 times the shares on offer.

The Gujarat-based pharma company develops and manufactures products focusing on women's healthcare, cardio-diabetes, among other therapeutic areas.

As of Sunday, 14 December 2025, the grey market premium (GMP) of the Corona Remedies IPO stands at Rs.295 per share. With the upper price band of the public issue at Rs.1,062, the company's shares are expected to ...